Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Journal of Hematology & Oncology
|
November 10, 2023
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
Narendranath Epperla, Lei Feng, Nirav N Shah, et al.
The Oncologist
|
April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma
Reid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
American Journal of Hematology
|
March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.
Blood Advances
|
March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
Reid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Cancer
|
October 1, 2019
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure
Emily C Ayers, Shaoying Li, L Jeffrey Medeiros, et al.
Leukemia & Lymphoma
|
March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort
Prashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Blood Advances
|
October 21, 2022
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2021
Burkitt Lymphoma International Prognostic Index
Adam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Blood
|
September 27, 2021
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Journal of Hematology & Oncology
|
November 10, 2023
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
Narendranath Epperla, Lei Feng, Nirav N Shah, et al.
The Oncologist
|
April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma
Reid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
American Journal of Hematology
|
March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.
Blood Advances
|
March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
Reid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Cancer
|
October 1, 2019
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure
Emily C Ayers, Shaoying Li, L Jeffrey Medeiros, et al.
Leukemia & Lymphoma
|
March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort
Prashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Blood Advances
|
October 21, 2022
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2021
Burkitt Lymphoma International Prognostic Index
Adam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Blood
|
September 27, 2021
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, et al.
Page
of 4